Skip to main content
Year archive

VITASORA HEALTH LIMITED — 2021 filings

All 46 regulatory filings released by VITASORA HEALTH LIMITED (VHL) in 2021, sourced directly from the official regulator.

46 Filings
2021 Period
2021 filings (46)
Filing Released Lang
Respiri enters Distribution/Marketing Agreement in USA 3 pages 144.2KB
Capital/Financing Update
2021-12-22 English
Respiri to present today at MST Financial Forum 2 pages 137.1KB
Investor Presentation
2021-11-24 English
Respiri to present at NWR Virtual Healthcare Day 2 pages 117.8KB
Investor Presentation
2021-11-21 English
AGM - Chairman's Address and CEO presentation 27 pages 2.1MB
AGM Information
2021-11-14 English
Results of AGM 3 pages 175.0KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-14 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 310.8KB
Interim / Quarterly Report Q1 2022
2021-10-25 English
Notice of General Meeting 16 pages 757.5KB
AGM Information
2021-10-13 English
Preliminary Final Report 77 pages 4.7MB
Annual Report FY 2021
2021-08-26 English
Annual Report - App 4G 14 pages 269.5KB
Regulatory Filings
2021-08-26 English
Annual Report - Corporate Governance Statement 13 pages 159.5KB
Governance Information
2021-08-26 English
NWR Conference Presentation - amended 25 pages 2.9MB
Investor Presentation
2021-08-04 English
NWR Conference Presentation 23 pages 3.2MB
Investor Presentation
2021-08-02 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 319.5KB
Interim / Quarterly Report Q4 2021
2021-07-29 English
Respiri to present at NWR Virtual Investor Conference 2 pages 117.5KB
Investor Presentation
2021-07-28 English
Top 20 shareholders and Distribution Schedule 4 pages 252.7KB
Regulatory Filings
2021-07-20 English
Clarification Announcement 2 pages 394.5KB
Regulatory Filings
2021-07-04 English
Response to ASX Query 9 pages 502.6KB
Regulatory Filings
2021-07-01 English
Pharmacy Network to Commence Sales of wheezo 2 pages 119.3KB
Regulatory Filings
2021-06-22 English
Webinar presentation - Investor Update 23 pages 3.1MB
Capital/Financing Update
2021-06-22 English
Investor webinar & Q&A 2 pages 117.4KB
Investor Presentation
2021-06-21 English
Change of Director's Interest Notice - MM 7 pages 560.5KB
Director's Dealing
2021-06-21 English
Trading Update 2 pages 123.2KB
Capital/Financing Update
2021-06-14 English
wheezo Registered and Approved for Sale in the UK Market 2 pages 121.5KB
Regulatory Filings
2021-06-10 English
wheezo production update &Chief Commercial Offer appointment 3 pages 378.2KB
Board/Management Information
2021-05-30 English
Major Shareholder Update 5 pages 969.2KB
Regulatory Filings
2021-05-26 English
Proposed issue of Securities - RSH 5 pages 27.9KB
Capital/Financing Update
2021-04-29 English
Appendix 4C - quarterly 9 pages 315.5KB
Interim / Quarterly Report Q3 2021
2021-04-28 English
Respiri Partnership with TerryWhite Chemmart Group 2 pages 118.1KB
Regulatory Filings
2021-04-27 English
Respiratory Physician led programme launching in Australia 2 pages 119.1KB
Regulatory Filings
2021-03-28 English
Strategic Advisor Appointments and UK Update 3 pages 134.1KB
Board/Management Information
2021-03-24 English
US FDA Clearance received 3 pages 156.1KB
Regulatory Filings
2021-03-22 English
Investor Presentation 11 pages 2.0MB
Investor Presentation
2021-03-22 English
Webinar and Q&A to be held tomorrow morning 1 page
Regulatory Filings
2021-03-21 English
Investor Presentation - NWR conference 19 pages 2.4MB
Investor Presentation
2021-03-18 English
Trading Halt 2 pages 529.1KB
Regulatory Filings
2021-03-18 English
Proposed issue of Securities - RSH 5 pages 27.0KB
Capital/Financing Update
2021-03-17 English
Appendix 2A - exercise of options 16 pages 260.0KB
Capital/Financing Update
2021-03-17 English
Respiri to present at NWR Comm.s Virtual Investor Conference 1
Investor Presentation
2021-03-14 English
Half Year Accounts 22 pages 474.1KB
Interim / Quarterly Report H1 2021
2021-02-18 English
Pharmacy Catalyst Members In-Pharmacy Asthma Mgt Program 3 pages 123.6KB
Regulatory Filings
2021-02-07 English
Change of Director's Interest Notice - NS 13 pages 647.1KB
Director's Dealing
2021-02-01 English
Change of Director's Interest Notice - MM 5 pages 432.5KB
Director's Dealing
2021-02-01 English
Change of Director's Interest Notice - TD 3 pages 229.8KB
Director's Dealing
2021-02-01 English
Appendix 4C - quarterly 9 pages 339.8KB
Interim / Quarterly Report Q2 2021
2021-01-26 English
Appendix 2A - exercise of options 16 pages 260.6KB
Capital/Financing Update
2021-01-17 English
SuperChem to Commence Sales of wheezo 2 pages 101.3KB
Regulatory Filings
2021-01-13 English